A Case of Refractory Eosinophilic Gastrointestinal Disease Successfully Treated With Dupilumab

ACG Case Rep J. 2023 Nov 6;10(11):e01187. doi: 10.14309/crj.0000000000001187. eCollection 2023 Nov.

Abstract

Eosinophilic infiltration of the gastrointestinal (GI) tract beyond the esophagus is a rare condition in adults with limited data on treatment. Current treatments with steroids and diet modifications have shown benefit, but when these treatments fall short, there is little research-driven guidance for further recommendations. We present a case of eosinophilic GI disease with extensive involvement of the GI tract successfully treated with dupilumab after failure of traditional treatment occurred.

Keywords: dupliumab; eosinophilic gastrointestinal diseases; gastrointestinal tract.

Publication types

  • Case Reports